3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Sponsor Class
INDIV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
82
Leukemia, Myeloid, Chronic-Phase
22
Leukemia
21
Gastrointestinal Stromal Tumors
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Neoplasms
8
Blast Crisis
7
Neoplasm Metastasis
6
Philadelphia Chromosome
4
Myeloproliferative Disorders
4
Melanoma
4
Leukemia, Myeloid
4
Bone Marrow Diseases
4
Recurrence
3
Leukemia, Myeloid, Acute
3
Hematologic Diseases
3
Bronchiolitis Obliterans Syndrome
3
Synovitis, Pigmented Villonodular
2
Ovarian Neoplasms
2
Neoplasm, Residual
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Substance Withdrawal Syndrome
1
Sarcoma
1
Retroperitoneal liposarcoma
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Piebaldism
1
Peritoneal Neoplasms
1
Neurofibromatoses
1
Interventions
Doxorubicin
25
Gemcitabine
16
Trabectedin
12
Ifosfamide
12
Radiotherapy
11
Docetaxel
10
Dacarbazine
8
pazopanib
7
Nivolumab
6
Specimen Handling
5
liposomal doxorubicin
4
Temozolomide
4
Biopsy
4
pembrolizumab
3
Sunitinib
3
Sorafenib
3
Radiation
3
Magnetic Resonance Spectroscopy
3
Filgrastim
3
rucaparib
2
pegfilgrastim
2
olaratumab
2
eribulin
2
durvalumab
2
cixutumumab
2
cemiplimab
2
brostallicin
2
belinostat
2
avelumab
2
X-Rays
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Leiomyosarcoma
×
nilotinib
×
Clear all
NCT02587169
2015-10-27
GEIS-27
Broto, Javier MartÃn, M.D.
Phase 1/2
Unknown
40 enrolled